| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0041 | 0.9 |